New Evidence Further Defines Distinct Clinical Considerations for Transcatheter Aortic Valve Replacement (TAVR) in Aortic Regurgitation (AR) and ...
An opt-out system seems to help, but there’s more work to do to meet performance goals endorsed by the AHA and ACC.
JenaValve today announced new clinical findings for its Trilogy TAVR system shared last week at the New York Valves 2026 ...
In severe disease of the aortic valve, choosing a new heart valve is especially difficult for young women who want to become pregnant.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results